NCT07196540 2025-09-29IP rmhTNF-NC + Tislelizumab + Palliat RT for GIT Tumor Malignant Ascites After Failed Std TxSun Yat-sen UniversityPhase 2 Not yet recruiting78 enrolled
NCT06794073 2025-08-29Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical StudyShanghai Zhongshan HospitalPhase NA Not yet recruiting17 enrolled